Unique Topography of DNA-protein Interactions in the Non-coding Region of Epidermodysplasia Verruciformis-associated Human Papillomaviruses

References

1. Angel P., Imagawa M., Chiu R., Stein B., Imbra R. J., Rahmsdorf H. J., Jonat C., Herrlich P., Karin M. 1987; Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729–739
   [Google Scholar]
2. Boshart M., Weber F., Jahn G., Dorsch-Hasler K., Flecken-stein B., Schaffner W. 1985; A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521–530
   [Google Scholar]
3. Bradford M. M. 1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
   [Google Scholar]
4. Brand A. H., Micklem G., Nasmyth K. 1987; A yeast silencer contains sequences that can promote autonomous plasmid replication and transcriptional activation. Cell 51:709–719
   [Google Scholar]
5. Chan W.-K., Chong T., Bernard H.-U., Klock G. 1990; Transcription of the transforming genes of the oncogenic human papillomavirus 16 is stimulated by tumor promoters through AP 1 binding sites. Nucleic Acids Research 18:763–769
   [Google Scholar]
6. Cripe T. P., Alderborn A., Anderson R. D., Parkkinen S., Bergman P., Haugen T. H., Pettersson U., Turek L. P. 1990; Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-l-responsive modules. New Biologist 2:450–463
   [Google Scholar]
7. Dignam J. D., Lebovitz R. M., Roeder R. G. 1983; Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Research 11:1475–1489
   [Google Scholar]
8. Eckdahl T. T., Anderson J. N. 1990; Conserved DNA structures in origins of replication. Nucleic Acids Research 18:1609–1612
   [Google Scholar]
9. Ensser A., Pfister H. 1990; Epidermodysplasia verruciformis associated papillomaviruses present a subgenus-specific organization of the regulatory genome region. Nucleic Acids Research 18:3919–3922
   [Google Scholar]
10. Fried M., Crothers D. M. 1981; Equilibra and kinetics of lac-repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Research 23:6505–6525
    [Google Scholar]
11. Fuchs P. G., Pfister H. 1990; Papillomaviruses in epidermodysplasia verruciformis. Papillomavirus Report 1:1–4
    [Google Scholar]
12. Fuchs P. G., Iftner T., Weninger J., Pfister H. 1986; Epidermodysplasia verruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis. Journal of Virology 58:626–634
    [Google Scholar]
13. Fuchs P. G., Reh H., Helbl V., Ensser A., Zimmermann R., Pfister H. 1990; Transcription-modulating elements and protein binding motifs in the regulatory genome regions of epidermodysplasia verruciformis-associated human papillomaviruses. UCLA Symposia on Molecular Biology New Series 124:501–505
    [Google Scholar]
14. Garcia-Carranca A., Thierry F., Yaniv M. 1988; Interplay of viral and cellular protein along the long control region of human papillomavirus type 18. Journal of Virology 62:4321–4330
    [Google Scholar]
15. Gassenmaier A., Lammel M., Pfister H. 1984; Molecular cloning and characterization of the DNAs of human papillomaviruses 19, 20 and 25 from a patient with epidermodysplasia verruciformis. Journal of Virology 52:1019–1023
    [Google Scholar]
16. Gloss B., Bernard H.-U. 1990; The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. Journal of Virology 64:5577–5584
    [Google Scholar]
17. Gloss B., Chong T., Bernard H.-U. 1989a; Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNaseI-protected segments coincides with the location of the cell-type-specific enhancer. Journal of Virology 63:1142–1152
    [Google Scholar]
18. Gloss B., Yeo-Gloss M., Meisterernst M., Rogge L., Win-nakker E. L., Bernard H. U. 1989b; Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Research 17:3519–3533
    [Google Scholar]
19. Gronostajski R. M. 1986; Analysis of nuclear factor I binding to DNA using degenerate oligonucleotides. Nucleic Acids Research 14:9117–9132
    [Google Scholar]
20. Gutman A., Wasylyk B. 1990; The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO Journal 9:2241–2246
    [Google Scholar]
21. Halfter H., Kavety B., Vandekerckhove J., Kiefer F., Gallwitz D. 1989; Sequence, expression and mutational analysis of BAF 1, a transcriptional activator and ARS 1-binding protein of the yeast Saccharomyces cerevisiae. EMBO Journal 8:4265–4272
    [Google Scholar]
22. Hennighausen L., Lubon H. 1987; Interaction of protein with DNA in vitro. Methods in Enzymology 152:721–755
    [Google Scholar]
23. Iftner T. 1990; Papillomavirus genomes: sequence analysis related to functional aspects. In Papillomaviruses and Human Cancer pp 181–202 Edited by Pfister H. Boca Raton: CRC Press;
    [Google Scholar]
24. Iftner T., Fuchs P. G., Pfister H. 1989; Two independently transforming functions of human papillomavirus 8. Current Topics in Microbiology and Immunology 144:167–173
    [Google Scholar]
25. Jablonska S. 1990; Human papillomaviruses in skin carcinomas. In Papillomaviruses and Human Cancer pp 45–71 Edited by Pfister H. Boca Raton: CRC Press;
    [Google Scholar]
26. Jackson M. E., Campo M. S. 1991; Positive and negative E2-independent regulatory elements in the long control region of bovine papillomavirus type 4. Journal of General Virology 72:877–883
    [Google Scholar]
27. Johnson P. F., McKnight S. L. 1989; Eukaryotic transcriptional regulatory proteins. Annual Review of Biochemistry 58:799–839
    [Google Scholar]
28. Krubke J., Kraus J., Delius H., Chow L., Broker T., Iftner T., Pfister H. 1987; Genetic relationship among human papillomaviruses associated with benign and malignant tumours of patients with epidermodysplasia verruciformis. Journal of General Virology 68:3091–3103
    [Google Scholar]
29. Li R., Knight J. D., Jackson S. P., Than R., Botchan M. R. 1991; Direct interaction between Spl and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell 65:493–505
    [Google Scholar]
30. Maeda H., Araki K., Kitamura D., Wang J., Watanabe T. 1987; Nuclear factors binding to the human immunoglobin heavy-chain gene enhancer. Nucleic Acids Research 15:2851–2869
    [Google Scholar]
31. Marsh J. L., Erfle M., Wykes J. 1984; The pIC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation. Gene 32:481–485
    [Google Scholar]
32. Martin M. E., Piette J., Yaniv M., Tang W.-J., Folk W. R. 1988; Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins. Proceedings of the National Academy of Sciences, U. S. A. 85:5839–5843
    [Google Scholar]
33. Offord E. A., Beard P. 1990; A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter. Journal of Virology 64:4792–4798
    [Google Scholar]
34. Orth G. 1987; Epidermodysplasia verruciformis. In The Papovaviri-dae pp 199–244 Edited by Salzman N. P., Howley P. M. New York: Plenum Press;
    [Google Scholar]
35. Parslow T. G., Blair D. L., Murphy W. J., Granner D. K. 1984; Structure of the 5′ ends of immunoglobulin genes: a novel conserved sequence. Proceedings of the National Academy of Sciences, U.S.A. 81:2650–2654
    [Google Scholar]
36. Patel N. U., Jameel S., Isom H., Siddiqui A. 1989; Interactions between nuclear factors and the hepatitis B virus enhancer. Journal of Virology 63:5293–5301
    [Google Scholar]
37. Reh H., Pfister H. 1990; Human papillomavirus type 8 contains cis-active positive and negative transcriptional control sequences. Journal of General Virology 71:2457–2462
    [Google Scholar]
38. Rhode P. R., Sweder K. S., Oegema K. F., Campbell J. 1989; The gene encoding ARS-binding factor I is essential for the viability of yeast. Genes and Development 3:1926–1939
    [Google Scholar]
39. Rørth P., Nerlov C., Blasi F., Johnsen M. 1990; Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. Nucleic Acids Research 18:5009–5017
    [Google Scholar]
40. Royer H. D., Freyaldenhoven M. P., Napierski I., Spitkovsky D. D., Bauknecht T., Dathan N. 1991; Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated. Nucleic Acids Research 19:2363–2371
    [Google Scholar]
41. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
42. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, U.S.A. 74:5463–5467
    [Google Scholar]
43. Schneider R., Gander I., Muller U., Mertz R., Winnacker E. L. 1986; A sensitive and rapid gel retardation assay for nuclear factor I and other DNA-binding proteins in crude nuclear extracts. Nucleic Acids Research 14:1303–1317
    [Google Scholar]
44. Schöler H. P., Gruss P. 1985; Cell-type specific transcriptional enhancement in vitro requires the presence of trans-acting factors. EMBO Journal 4:3005–3013
    [Google Scholar]
45. Schwarz E., Dürst M., Demankowski C., Lattermann O., Zech R., Wolfsperger E., Suhai S., Zur Hausen H. 1983; DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO Journal 2:2341–2348
    [Google Scholar]
46. Seeberger R., Haugen T., Turek L., Pfister H. 1987; An enhancer of human papillomavirus type 8 is trans-activated by the bovine papillomavirus type-1 E2 function. Cancer Cells 5:33–38
    [Google Scholar]
47. Sibbet G. J., Campo M. S. 1990; Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16. Journal of General Virology 71:2699–2707
    [Google Scholar]
48. Steger G., Olszewsky M., Stockfleth E., Pfister H. 1990; Prevalence of antibodies to human papillomavirus 8 in human sera. Journal of Virology 64:4399–4406
    [Google Scholar]
49. Stenlund A., Botchan M. R. 1990; The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor. Genes and Development 4:123–136
    [Google Scholar]
50. Wasylyk B., Wasylyk C., Flores P., Begue A., Leprince D., Stehelin D. 1990; The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature, London 348:191–193
    [Google Scholar]
51. Wildeman A. G., Sassone-Corsi P., Grundstrom T., Zenke M., Chambon P. 1984; Stimulation of in vitro transcription from the SV40 early promoter by the enhancer involves a specific transacting factor. EMBO Journal 3:3129–3133
    [Google Scholar]
52. Wu C. 1985; An exonuclease protein assay reveals heat-shock element and TATA box DNA-binding proteins in crude nuclear extracts. Nature, London 317:84–87
    [Google Scholar]
53. Zachow K. R., Ostrow R. S., Faras A. J. 1987; Nucleotide sequence and genome organization of human papillomavirus type 5. Virology 158:251–254
    [Google Scholar]
54. Zenke M., Grundström T., Matthes H., Wintzerith M., Schatz C., Wildeman A., Chambon P. 1986; Multiple sequence motifs are involved in SV40 enhancer function. EMBO Journal 5:387–397
    [Google Scholar]
55. Zur Hausen H., Schneider A. 1987; The role of papillomaviruses in human anogenital cancers. In The Papovaviridae vol 2 pp 245–263 Edited by Salzman N. P., Howley P. M. New York: Plenum Press;
    [Google Scholar]